Table 1 The summary of the results of each treatment group
From: The course of metastatic prostate cancer under treatment
Parameters | BSO n = 12 | BSO + AA n = 18 | LH-RH + AA n = 26 | WHOLE GROUP n = 56 | ||||
|---|---|---|---|---|---|---|---|---|
| Â | Median | Mean | Median | Mean | Median | Mean | Median | Mean |
The PSA (ng/ml) values before teratment | 91 | 171 | 143 | 383,7 | 115 | 626,5 | 110 | 423,8 |
Gleason score | 7 | 7,33 | 7 | 7,5 | 7 | 7,52 | 7 | 7,4 |
The nadir PSA (ng/ml) after treatment | 1,3 | 31,01 | 3,6 | 37,47 | 2,4 | 7,87 | 2,71 | 21,68 |
The time to the nadir PSA (months) | 3 | 5,9 | 4,5 | 6,45 | 8,5 | 9,27 | 6 | 7,44 |
The time to hormonal resistance (months) | 18,7 | 32,77 | 17 | 26,48 | 21 | 27,3 | 20 | 30,28 |
The PSA (ng/ml) at the hormonal resistance | 103,5 | 124,2 | 54 | 163,7 | 38,5 | 890,6 | 54 | 489,9 |
Survival (months) | 25 | 45 | 47 | 45,25 | 32 | 34,35 | 34 | 42,67 |